Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes

Mishra, A; Tamari, R; DeZern, AE; Byrne, MT; Gooptu, M; Chen, YB; Deeg, HJ; Sallman, D; Gallacher, P; Wennborg, A; Hickman, DK; Attar, EC; Fernandez, HF

Mishra, A (通讯作者)，H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Moffitt Canc Ctr Magnolia Campus, Tampa, FL 33612 USA.

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (34): 3985

Abstract

PURPOSEOutcomes are poor in TP53-mutant (mTP53) acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), even after allogeneic hematopoietic ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索